Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial
Amadou Barry, Djibrilla Issiaka, Tiangoua Traore, Almahamoudou Mahamar, Boubacar Diarra, Issaka Sagara, Diakalia Kone, Ogobara K Doumbo, Patrick Duffy, Michal Fried, Alassane Dicko, Amadou Barry, Djibrilla Issiaka, Tiangoua Traore, Almahamoudou Mahamar, Boubacar Diarra, Issaka Sagara, Diakalia Kone, Ogobara K Doumbo, Patrick Duffy, Michal Fried, Alassane Dicko
Abstract
Background: Seasonal malaria chemoprevention (SMC), the administration of complete therapeutic courses of antimalarials to children aged 3-59 months during the malaria transmission season, is a new strategy recommended by the World Health Organization (WHO) for malaria control in Sahelian countries such as Mali with seasonal transmission. The strategy is a highly cost-effective approach to reduce malaria burden in these areas. Despite the substantial benefits of SMC on malaria infection and disease, the optimal approach to deliver SMC remains to be determined. While fixed-point delivery (FPD) and non-directly observed treatment (NDOT) by community health workers are logistically attractive, these need to be evaluated and compared to other modes of delivery for maximal coverage.
Methods: To determine the optimal mode fixed-point (FPD) vs door-to-door delivery (DDD); directly observed treatment (DOT) vs. non- directly observed treatment (NDOT)), 31 villages in four health sub-districts were randomized to receive three rounds of SMC with Sulfadoxine-pyrimethamine plus Amodiaquine (SP+AQ) at monthly intervals using one of the following methods: FPD+DOT; FPD+NDOT; DDD+DOT; DDD+NDOT. The primary endpoint was SMC coverage assessed by cross-sectional survey of 2,035 children at the end of intervention period.
Results: Coverage defined as the proportion of children who received all three days of SMC treatment during the three monthly rounds based information collected by interview (primary endpoint) was significantly higher in children who received SMC using DDD 74% (95% CI 69% - 80%) compared to FPD 60% (95% CI 50% - 70%); p = 0.009. It was similar in children who received SMC using DOT or NDOT 65%, (95% CI 55% - 76%) versus 68% (95% CI 57% - 79%); p = 0.72.
Conclusions: In summary, door-to-door delivery of SMC provides better coverage than FPD. Directly observed therapy, which requires more time and resources, did not improve coverage with SMC.
Trial registration: ClinicalTrials.gov NCT02646410.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- World Health Organization WHO (2015).
- Dicko A, Diallo AI, Tembine I, Dicko Y, Dara N, Sidibe Y, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial. PLoS Med 2011; 8: 1000407.
- World Health Organization WHO Global Malaria Programme (2012). WHO policy recommendation: Seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. March 2012. Available at:
- WHO implementation guidelines: Seasonal malaria chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field guide.
- Greenwood B, Bojang K, Tagbor H, Pagnoni F. Combining community case management and intermittent preventive treatment for malaria. Trends Parasitol. 2011. November;27(11):477–80. doi: .
- Kweku M, Webster J, Adjuik M, Abudey S, Greenwood B, Chandramohan D. Options for the delivery of intermittent preventive treatment for malaria to children: a community randomised trial. PLoS One. 2009. September 30;4(9):e7256 doi:
- Bojang KA, Akor F, Conteh L, Webb E, Bittaye O, Conway DJ, et al. Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial. PLoS Med. 2011. February 1;8(2):e1000409 doi:
- Dicko A, Toure SO, Traore M, Sagara I, Toure OB, Sissoko MS, Diallo AT, Rogier C, Salomon R, de Sousa A, Doumbo OK. Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial. BMC Public Health. 2011. July 18;11:573 doi:
- Rao J. N. K., and Scott A. J. 1984. On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Annals of Statistics 12: 46–60.
- Strachan CE, Kana M, Martin S, Dada J, Wandera N, Marasciulo M, et al. The use of formative research to inform the design of a seasonal malaria chemoprevention intervention in northern Nigeria. Malar J. 2016. September 15;15:474 doi:
- Ntuku HM, Ruckstuhl L, Julo-Réminiac JE, Umesumbu SE, Bokota A, Tshefu AK, et al. Long-lasting insecticidal net (LLIN) ownership, use and cost of implementation after a mass distribution campaign in Kasaï Occidental Province, Democratic Republic of Congo. Malar J. 2017. January 9;16(1):22 doi:
- Mangam K, Fiekowsky E, Bagayoko M, Norris L, Belemvire A, Longhany R, et al. Feasibility and Effectiveness of mHealth for Mobilizing Households for Indoor Residual Spraying to Prevent Malaria: A Case Study in Mali. Glob Health Sci Pract. 2016. June 27;4(2):222–37. doi:
- Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, et al. Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali. BMC Infect Dis. under review.
- Rahman MM, Dondorp AM, Day NP, Lindegardh N, Imwong M, Faiz MA, et al. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Trans R Soc Trop Med Hyg. 2008. September;102(9):861–7. doi:
- Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, et al. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet. 2005. April 23–29;365(9469):1467–73. doi:
- Cissé B, Ba EH, Sokhna C, NDiaye JL, Gomis JF, Dial Y, et al. Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial. PLoS Med. 2016. November 22;13(11):e1002175 doi:
Source: PubMed